[{"Assets_0_Q1_USD":"1573600000.0","CIK":"899923","CommonStockSharesConverted_0_Q1_shares":"74700000.0","CommonStockSharesOutstanding_0_Q1_shares":"74700000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.01","EarningsPerShareDiluted_1_Q1_USD":"-0.01","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"7800000.0","NetIncomeLoss_1_Q1_USD":"-700000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q1_USD":"-800000.0","RevenuesConverted_1_Q1_USD":"202300000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"1102200000.0","StockholdersEquity_0_Q1_USD":"1102200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"73000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"73000000.0","filed":"20181107","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"MYRIAD GENETICS INC","period":"20180930","qtrs":"0","uom":"USD"}]